Related Experiment Video
Updated: Jan 16, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Impact of the Transition Council in Type 1 Diabetes: Bridging the Gap to Adult Care
Erhan Hocaoglu1, Hatice Nursoy2, Filiz Mercan Saridas1
1Division of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.
Aim:
This retrospective study evaluates the impact of the transition council on clinic attendance, glycaemic control and complications in type 1 diabetes.
Methods:
Since 2015, monthly multidisciplinary transition meetings (transition councils) have been held involving paediatric and adult endocrinology departments at Bursa Uludag University Hospital, Turkey. The study retrospectively compared outcomes of type 1 diabetes patients who transitioned to adult care via the council versus standard transition. A total of 180 patients (90 in each group) aged at transition 18-21 years (58.9% male) were included.
Results:
Within 6 months post-transition, 84.9% of council patients (exposed group) and 54.1% of the standard care group attended at least one visit (p < 0.001). Regular follow-up during the first year was significantly higher in the exposed group (58.1% vs. 29.7%, p < 0.001); rates were similar between groups in subsequent years. HbA1c levels increased significantly 1 year after transition in the standard care group (p = 0.025), while the exposed group remained stable (p = 0.719). No significant differences were observed in hospitalisation or diabetic ketoacidosis.
Conclusion:
This transition model may improve regular follow-up rates during the challenging first year of transition and help prevent additional deterioration in glycaemic control compared to standard care. Prospective randomised trials could strengthen these findings.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Kidney Transplant III: Nursing Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

